Medicare Enrolled

Dr. Emily Matlin, D.O.

Neurology · Harrisburg, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
4830 LONDONDERRY RD, Harrisburg, PA 17109
7176572595
Registered in NPPES since 2006
NPI: 1558322974 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Matlin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Matlin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Matlin

Dr. Emily Matlin is a neurology specialist in Harrisburg, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Matlin performed 157 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Matlin received a total of $72,296 from 45 pharmaceutical and/or device companies across 630 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Matlin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 157 Medicare services $72,296 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
157
Medicare services
Bottom 23% in PA for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
98 $84 $160
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
37 $55 $110
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
22 $93 $160
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$72,296
Total received (2018-2024)
Avg $10,328/year across 7 years
Top 8% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
630
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,065
2023
$1,808
2022
$2,069
2021
$2,339
2020
$20,853
2019
$32,707
2018
$11,455

Payments by company (2024)

ABBVIE INC.
$347
Lundbeck LLC
$163
EMD Serono, Inc.
$153
PFIZER INC.
$149
E.R. Squibb & Sons, L.L.C.
$92
Celgene Corporation
$41
Lilly USA, LLC
$29
Amgen Inc.
$25
Biogen, Inc.
$25
Teva Pharmaceuticals USA, Inc.
$22
Neurocrine Biosciences, Inc.
$19
Top 3 companies account for 62.2% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$35,771
Teva Pharmaceuticals USA, Inc.
$16,001
Allergan, Inc.
$9,547
EMD Serono, Inc.
$1,926
Neurocrine Biosciences, Inc.
$1,122
ABBVIE INC.
$917
Biogen, Inc.
$730
Amgen Inc.
$662
Novartis Pharmaceuticals Corporation
$563
E.R. Squibb & Sons, L.L.C.
$508
Lundbeck LLC
$501
GENZYME CORPORATION
$498
Biohaven Pharmaceutical Holding Company Ltd.
$456
Celgene Corporation
$380
AbbVie Inc.
$305
PFIZER INC.
$283
Genentech USA, Inc.
$257
UCB, Inc.
$226
Avanir Pharmaceuticals, Inc.
$216
Biohaven Pharmaceuticals, Inc.
$208
US WorldMeds, LLC
$143
Allergan Inc.
$116
Novo Nordisk Inc
$111
Synergy Pharmaceuticals Inc
$106
Acorda Therapeutics, Inc
$105
ASSERTIO THERAPEUTICS, Inc.
$90
Supernus Pharmaceuticals, Inc.
$81
Impax Laboratories, Inc.
$54
Sunovion Pharmaceuticals Inc.
$45
Amneal Pharmaceuticals LLC
$37
Assertio Therapeutics, Inc.
$37
Bayer HealthCare Pharmaceuticals Inc.
$29
Abbott Laboratories
$27
Merck Sharp & Dohme Corporation
$25
Mallinckrodt Enterprises LLC
$25
Bausch Health US, LLC
$24
IMPEL PHARMACEUTICALS INC.
$24
Promius Pharma LLC
$24
Endo Pharmaceuticals Inc.
$22
GlaxoSmithKline, LLC.
$19
SANOFI PASTEUR INC.
$18
Egalet US Inc
$15
Adamas Pharmaceuticals, Inc.
$15
Kyowa Kirin, Inc.
$15
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 84.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · COPAXONE · Cambia · ELIQUIS · EMGALITY · EVENITY · FLUZONE HIGH-DOSE · FreeStyle Libre · GILENYA · GOCOVRI · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · JANUVIA · LEMTRADA · LYRICA · MAVENCLAD · MAYZENT · MIGRANAL · MS DISEASE STATE · MYOBLOC · Mavenclad · NASCOBAL · NOURIANZ · NUEDEXTA · NURTEC ODT · OCREVUS · ONGENTYS · OPDIVO · Ongentys · Ozempic · PLEGRIDY · QULIPTA · REYVOW · RYTARY · Rebif · SHINGRIX · SPRIX · TECFIDERA · TROKENDI XR · TYSABRI · Trudhesa · Trulance · UBRELVY · VRAYLAR · VUMERITY · VYEPTI · Vimpat · Xadago · ZAVZPRET · ZELAPAR · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Harrisburg?
Compare neurologists in the Harrisburg area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
85
County median income
$74,159
Nearest hospital to ZIP centroid (approximate)
UPMC PINNACLE HOSPITALS
3.3 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Matlin is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Matlin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Matlin performed 98 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Matlin receive payments from pharmaceutical companies?
Yes. Dr. Matlin received a total of $72,296 from 45 companies across 630 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Matlin's costs compare to other neurologists in Harrisburg?
Dr. Matlin's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Matlin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →